Lincoln Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹191 crore and net profit of ₹20 crore for the September 2026 quarter.
Lincoln Pharmaceuticals (NSE: LINCOLN) closed at ₹511.90 on 20 Nov 2026, down 4.0% over the past year. Its market capitalisation is ₹1,025 crore and it trades at 10.6 times earnings.
Incorporated in 1979, Lincoln Pharmaceuticals Ltd is in the business of manufacturing and trading of pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.